郑州微飒生物科技有限责任公司 咨询热线:0371-88821766
行业动态

行业动态

追踪行业前沿,洞察产业趋势

肿瘤模型MEN1309/OBT076, a First-In-Class Antibody-Drug Conjugate Targeting CD205 in Solid Tumors.

期刊:Molecular cancer therapeutics发表年份:2019作者:Giuseppe Merlino; Alessio Fiascarelli; Mario Bigioni; Alessandro Bressan; Corrado Carrisi; Daniela Bellarosa; Massimiliano Salerno; Rossana Bugianesi; Rosanna Manno; Cristina Bernadó Morales; Joaquin Arribas; Rachel L Dusek; James E Ackroyd; Phuoc Hu

肿瘤模型Hijacking antibody-induced CTLA-4 lysosomal degradation for safer and more effective cancer immunotherapy.

期刊:Cell research发表年份:2019作者:Yan Zhang; Xuexiang Du; Mingyue Liu; Fei Tang; Peng Zhang; Chunxia Ai; James K Fields; Eric J Sundberg; Olga S Latinovic; Martin Devenport; Pan Zheng; Yang Liu

肿瘤模型Pt-Fe ferrocenyl compounds with hydroxyquinoline ligands show selective cytotoxicity on highly proliferative cells.

期刊:Journal of inorganic biochemistry发表年份:2019作者:Feriannys Rivas; Andrea Medeiros; Marcelo Comini; Leopoldo Suescun; Esteban Rodríguez Arce; Marta Martins; Teresa Pinheiro; Fernanda Marques; Dinorah Gambino

肿瘤模型Design, Synthesis, and in Vitro Biological Evaluation of 14-Hydroxytylophorine-dichloroacetate Co-drugs as Antiproliferative Agents.

期刊:Chemical & pharmaceutical bulletin发表年份:2019作者:Ziad Omran; Mohamed Alarja; Ashraf N Abdalla; Munjed M Ibrahim; Mohammad A Hossain; Linwei Chen; Yuxiu Liu; Qingmin Wang